Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trial
- DOI
- 10.1016/j.eclinm.2022.101809
- Published
- 2023-02
- Container
- eClinicalMedicine
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.eclinm.2022.101809,
title = {Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trial},
author = {Robin von Rotz and Eva M. Schindowski and Johannes Jungwirth and Anna Schuldt and Nathalie M. Rieser and Katharina Zahoranszky and Erich Seifritz and Albina Nowak and Peter Nowak and Lutz Jäncke and Katrin H. Preller and Franz X. Vollenweider},
year = {2023},
journal = {eClinicalMedicine},
doi = {10.1016/j.eclinm.2022.101809},
url = {https://doi.org/10.1016/j.eclinm.2022.101809}
}RIS
TY - JOUR TI - Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trial AU - Robin von Rotz AU - Eva M. Schindowski AU - Johannes Jungwirth AU - Anna Schuldt AU - Nathalie M. Rieser AU - Katharina Zahoranszky AU - Erich Seifritz AU - Albina Nowak AU - Peter Nowak AU - Lutz Jäncke AU - Katrin H. Preller AU - Franz X. Vollenweider PY - 2023 JO - eClinicalMedicine DO - 10.1016/j.eclinm.2022.101809 UR - https://doi.org/10.1016/j.eclinm.2022.101809 ER -
APA
Rotz, R. V., Schindowski, E. M., Jungwirth, J., Schuldt, A., Rieser, N. M., Zahoranszky, K., Seifritz, E., Nowak, A., Nowak, P., Jäncke, L., Preller, K. H., & Vollenweider, F. X. (2023). Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trial. eClinicalMedicine. https://doi.org/10.1016/j.eclinm.2022.101809
Source records
- crossref · retrieved 2026-09-25T10:28:03.193Z